- Home
- / Jointown Pharmaceutical Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jointown Pharmaceutical Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥5.1
2024-10-29
Market Capitalization
¥25.8 B
2024-10-29
Revenue
¥160.8 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 86.7B | 99.0B | 110.6B | 122.1B | 139.9B | 149.5B | 151.3B | 160.8B |
| Cost of goods sold | 79.6B | 90.8B | 100.9B | 112.6B | 129.5B | 138.0B | 140.0B | 148.8B |
| Gross profit | 7.3B | 8.5B | 9.7B | 9.5B | 10.6B | 11.7B | 11.4B | 12.1B |
| Gross profit margin, % | 8.4% | 8.5% | 8.8% | 7.8% | 7.6% | 7.8% | 7.6% | 7.5% |
| Operating expense total | 4.3B | 4.8B | 5.5B | 6.0B | 2.9B | 6.9B | 6.9B | 7.4B |
| Depreciation and amortization | 420.3M | 504.5M | 524.3M | 566.4M | 4.2B | 641.6M | 739.7M | 1.5B |
| EBITDA | 3.0B | 3.7B | 4.3B | 3.6B | 7.9B | 4.9B | 4.6B | 4.9B |
| EBITDA margin, % | 3.5% | 3.8% | 3.8% | 3.0% | 5.7% | 3.3% | 3.1% | 3.1% |
| EBIT | 2.6B | 3.4B | 5.2B | 4.3B | 3.7B | 4.1B | 3.5B | 3.2B |
| EBIT margin, % | 3.0% | 3.4% | 4.7% | 3.5% | 2.6% | 2.8% | 2.3% | 2.0% |
| Interest income | 103.6M | 105.5M | 148.6M | 140.2M | 192.1M | 222.8M | 171.0M | 140.9M |
| Interest expense | 889.1M | 1.2B | 1.0B | 1.1B | 1.2B | 1.3B | 1.3B | 1.0B |
| Pre tax profit | 1.8B | 2.3B | 4.3B | 3.4B | 2.8B | 3.0B | 3.6B | 3.3B |
| Income tax expense | 449.3M | 536.0M | 948.9M | 754.9M | 552.6M | 701.2M | 851.0M | 880.2M |
| Net Income | 1.4B | 1.8B | 3.4B | 2.6B | 2.3B | 2.3B | 2.8B | 2.4B |